Sandbox Reserved 1449: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 34: Line 34:
== References ==
== References ==
<references/>
<references/>
Contet, Candice, et al. “Mu Opioid Receptor: a Gateway to Drug Addiction.” Current Opinion in Neurobiology, 19 May 2004, pp. 370–378., doi:10.1016/s0959-4388(04)00072-8.
Matthes, Hans W. D., et al. “Loss of Morphine-Induced Analgesia, Reward Effect and Withdrawal Symptoms in Mice Lacking the µ-Opioid-Receptor Gene.” Nature, vol. 383, no. 6603, 1996, pp. 819–823., doi:10.1038/383819a0.
National Institute on Drug Abuse. “Opioid Overdose Crisis.” NIDA, 6 Mar. 2018, www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis.
Pasternak, G. W., and Y.-X. Pan. “Mu Opioids and Their Receptors: Evolution of a Concept.” Pharmacological Reviews, vol. 65, no. 4, 2013, pp. 1257–1317., doi:10.1124/pr.112.007138.
Pasternak, Gavril, and Ying-Xian Pan. “Mu Opioid Receptors in Pain Management.” Acta Anaesthesiologica Taiwanica, vol. 49, no. 1, Mar. 2011, pp. 21–25., doi:10.1016/j.aat.2010.12.008.
Serohijos, Adrian W.r., et al. “Structural Basis for μ-Opioid Receptor Binding and Activation.” Structure, vol. 19, no. 11, 9 Nov. 2011, pp. 1683–1690., doi:10.1016/j.str.2011.08.003.